DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Fumaric Acid is an investigational drug.
There have been 15 clinical trials for Fumaric Acid. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Psoriasis, Sclerosis, and Lupus Erythematosus, Systemic. The leading clinical trial sponsors are Medical University of Vienna, Jochen Schmitt., and Singapore General Hospital.
There are six hundred and forty-two US patents protecting this investigational drug and seven international patents.
Recent Clinical Trials for Fumaric Acid
|A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis||LEO Pharma||Phase 4|
|A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis||Janssen-Cilag G.m.b.H||Phase 3|
|APremilast After FumaRic Acid Ester Treatment||Prof. Kristian Reich||N/A|
Top disease conditions for Fumaric Acid
Top clinical trial sponsors for Fumaric Acid
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Fumaric Acid||Start Trial||Carbostyril derivatives||Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP)||Start Trial|
|Fumaric Acid||Start Trial||Indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same||Fujisawa Pharmaceutical Company, Ltd. (Osaka, JP)||Start Trial|
|Fumaric Acid||Start Trial||Method for forming a metal film on the surface of a substrate metal||Harima Chemicals, Inc. (Hyogo, JP)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Fumaric Acid||Brazil||1100204||2008-10-31||Start Trial|
|Fumaric Acid||China||1028104||2008-10-31||Start Trial|
|Fumaric Acid||China||1042537||2008-10-31||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|